| abstract |
The present invention relates to compounds, compositions, and methods that are effective in modulating HCV gene expression using small interfering nucleic acids (siNA). The present invention also relates to compounds, compositions, and methods that are effective in modulating the expression or activity of other genes, including activity by RNA interference (RNAi) using HCV gene expression pathways and / or small nucleic acid molecules. Related. In particular, the present invention relates to small nucleic acids such as small interfering nucleic acids (siNA), small interfering RNA (siRNA), double stranded RNA (dsRNA), micro RNA (miRNA), and short hairpin RNA (shRNA) molecules. Features. |